Industry Intelligence

News & Quick Takes

IPMI headlines, market moves, and MDabroad commentary — updated as the industry moves.

IPMI
Asian Business Review · April 9, 2026

Insurance Gaps Expose Business Travellers to $150,000 Risks

Zurich data shows 53% of business travelers faced incidents abroad, with medical emergencies driving the majority of assistance claims. Coverage gaps are leaving employers exposed to six-figure liabilities — with inadequate TPA infrastructure as a primary failure point.

💼
Market Intelligence
GlobeNewswire · April 6, 2026

Yuzu Health Raises $35M to Modernize TPA Infrastructure

A new vertically integrated TPA raises $35M Series A to rebuild the claims processing, payments, and member administration stack for health plans. The round signals growing investor conviction that TPA infrastructure is broken — and overdue for a complete rebuild. MDabroad has been doing this for 26 years.

💰
Cost Containment
Health & Protection · March 2026

Why Advisers Are Now Assessing TPAs When Choosing Insurers

"Cost containment now combines analytics, strong provider management and continuous process improvement," says Nextcare's global head of health services. Brokers and advisers are scrutinizing TPA capability — not just price — when placing international health programs.

🔍
IPMI
Health & Protection · March 2026

WoA Convention: Three Subjects Leading the Future of IPMI in Latin America

Sustainability, growth, and AI were the defining themes at the World of Americas Convention 2026. LATAM's IPMI market is accelerating — and the winners will be operators with genuine on-the-ground infrastructure, not just digital interfaces.

🌎
Technology
MDabroad · April 2026

Smart Triage + AI: The Legal and Ethical Dilemma

AI-assisted triage is being deployed now in international assistance — but most of the industry isn’t confronting the hard questions. MDabroad breaks down the legal, ethical, and operational framework for doing it right.

🤖
Operations
MDabroad · April 2026

Air Ambulance: When to Transfer, When Not To, and Who Pays

Air ambulance is the most expensive single line item in international assistance — and one of the most mismanaged. Preventable spend in the hundreds of thousands of dollars happens when the decision framework is wrong.

✈️
Market Intelligence
MDabroad · April 2026

Hospital Pricing in the Americas: A Payer’s Market Guide

Published benchmarks tell you almost nothing about what your policyholder will actually be billed in Latin America. MDabroad’s 26-year on-the-ground network fills that gap.

🌎
Cost Containment
MDabroad · April 2026

How We Contain Costs: Repricing, UCR, and the Negotiation Playbook

International medical cost containment is not a single tactic — it’s a system. Programs that control their loss ratios year after year do it through layered intervention, not one-off negotiation.

📊
Market Intelligence
MDabroad · April 2026

Hospital Pricing Across Europe: Country by Country

Europe is not a single pricing environment. From Germany’s G-DRG system to Spain’s fragmented private hospital groups — what you’ll actually be billed varies dramatically. A country-by-country breakdown for IPMI payers.

🇪🇺
Cost Containment
MDabroad · March 2026

The International Patient Premium: Why Hospitals Charge Foreign Insurers More

Most published healthcare cost data reflects domestic contracted rates — not what a foreign insurer without a contract actually pays. The gap is larger than most programs model for.

🏥
Market Intelligence
MDabroad · March 2026

The Real Cost of International Medical Care — Region by Region

International medical cost data is one of the most poorly understood variables in insurance product design. Programs are routinely underpriced because designers rely on domestic benchmarks for markets that operate on entirely different economics.

💰
Cost Containment
MDabroad · March 2026

Hospital Pricing Across International Markets: What Every IPMI Payer Needs to Know

In most international markets, the rate a hospital charges a foreign insurer is not the rate it charges a domestic payer. The differential — what MDabroad calls the international patient premium — can range from 20% to over 300%.

🔬
Operations
MDabroad · March 2026

Patient Safety and Risk Mitigation in International Medical Cases

Patient safety in international assistance is a different problem than domestic healthcare. The safety risk is not just clinical — it’s logistical, informational, and structural. Major private hospitals in Brazil, Mexico, and Thailand are world-class. The gaps lie elsewhere.

🛡️
Operations
MDabroad · March 2026

Best Price vs. Best Facility: How MDabroad Chooses Providers in High-Stakes Cases

When a covered member requires a major procedure abroad, the provider selection decision determines clinical outcome and total cost simultaneously. Before cost enters the calculation, there must be a clinical floor.

🏥
Cost Containment
MDabroad · February 2026

The Hidden Cost of Slow Claims: Why Speed Matters Beyond Service

Claims speed is not a service quality metric. It is a cost containment lever, a working capital variable, and a program health indicator. Slow claims cost your program money in ways that never appear in a loss ratio report.

⏱️
Cost Containment
MDabroad · February 2026

What Procurement Teams Get Wrong About International TPA Selection

Every year, insurers arrive at TPA procurement armed with RFP templates and price benchmarks. And every year, a meaningful portion select the wrong partner — not because they lack diligence, but because they’re measuring the wrong things.

📝
Cost Containment
MDabroad · February 2026

U.S. Cost Containment: How to Push Patient Behavior Upstream

Most programs respond to U.S. cost exposure with retrospective tactics: bill review, UCR negotiation, case-by-case settlement. These tools have real value — but they engage after the cost is already incurred. The bigger lever is upstream.

🇺🇸
Financing
MDabroad · January 2026

How Balance-Sheet Financing Unlocks Provider Discounts

There’s a simple truth in healthcare economics that most insurers overlook: providers will accept less money if you pay them faster. MDabroad finances claims from its own balance sheet — and passes the savings directly to payers.

🏦
Cost Containment
MDabroad · January 2026

The Role of Hospitalists in Reducing Inpatient Costs

Most international insurers focus cost containment efforts on negotiating bills after discharge. By then, it’s too late. The biggest cost driver in U.S. inpatient claims isn’t the room rate — it’s length of stay. Hospitalists fix that upstream.

👨‍⚕️
Cost Containment
MDabroad · January 2026

Why LATAM Medical Networks Require Local Expertise

European and North American insurers often treat Latin America as a single market. It’s not. Brazil alone has a healthcare system larger than most European countries. Without local expertise, you’re flying blind on pricing, quality, and access.

🌳
Cost Containment
MDabroad · December 2025

What Is Medical Cost Containment? A Complete Guide

If you work in international health insurance, you’ve heard the term. But what does medical cost containment actually mean operationally? From first principles to advanced strategies — a complete guide for IPMI and travel insurance professionals.

📚
Cost Containment
MDabroad · December 2025

Why U.S. Hospital Claims Cost 52% Less with MDabroad

A routine appendectomy costs $3,000 in Spain and $33,000 in Miami. An ER visit for chest pain runs $18,000. MDabroad cuts that by 52% on average — through Aetna PPO access, hospitalist deployment, and smart triage that diverts 50% of calls from the ER.

💵
Cost Containment
MDabroad · March 23, 2026

Cost Containment in Latin America: Why Local Intelligence Wins

How dual pricing, unbundled billing, and currency risk inflate LATAM claims — and how MDabroad's 26-year on-the-ground network delivers 35–55% savings without compromising care.

🌎
Crisis Response
MDabroad · March 16, 2026

We're Still There: MDabroad's Ongoing Response to the UAE Crisis

As war exclusions halt insurance payouts across the UAE, MDabroad continues to provide assistance, telemedicine, and coordination services to stranded travelers — gratis. Working with local partners LGA Assistance and CONNEX, our team has coordinated dozens of telemedicine consultations and maintained 24/7 contact with members on the ground.

🇦🇪
LinkedIn
MDabroad · March 11, 2026

25 Years — Leadership Reflections with CFO Ralph Patino

🥂 After 25 years, one principle still guides how we operate. Our CFO shares his perspective on leadership, service, and the values that have shaped MDabroad. Because in global healthcare, doing things the right way still matters.

🎥
Analysis
MDabroad · March 11, 2026

The global IPMI market hit $38.8B in 2024 — colliding with 10.7% medical inflation, a 164% chargemaster markup gap, and 45–60 day claims cycles. The Middle East crisis this week is a live test of what those structural gaps look like in practice.

📊
Market Intelligence
Willis Towers Watson · November 2023 (via MDabroad)

Global Medical Trend Rate Hits 10.7% — First Double-Digit Year on Record

WTW's 2024 Global Medical Trends Survey shows medical cost inflation hit 10.7% in 2023, up from 7.4% the prior year — the first time global medical trend has broken double digits. IPMI programs are feeling this disproportionately for U.S.-routed cases.

📈
LinkedIn
MDabroad · August 2025

Patient Brokering: A Dangerous Ethical Issue in International Healthcare

Patient brokering — directing patients to specific facilities in exchange for referral fees — remains one of the most underreported ethical risks in international healthcare. What payors and assistance companies need to know to protect their members.

⚠️
IPMI
Health & Protection · October 2025

IPMI Providers Forecast ~10% Annual Premium Increases for Next Three Years

At the H&P House of Lords roundtable, IPMI market participants signalled sustained premium pressure ahead. "A domestic scheme is in the tens of thousands. An international scheme runs into hundreds of thousands — 10% on that soon adds up."

🏥
LinkedIn
MDabroad · July 2025

USD Devaluation in 2025: Critical Insights for Travel Insurers Worldwide

A weakening dollar reshapes the economics of international medical claims. What travel insurers and IPMI carriers need to model for their 2025 programs — and which markets feel the impact most acutely.

💵

Ready to reduce your international claims costs?

Talk to our team about how MDabroad can help.

Book a Strategy Call →